semaglutide weight loss after stopping November Blog Weight Regain After Ozempic, Wegovy

Food and Drug Administration (FDA) and are not intended for human or veterinary use, clinical use, diagnostic use, or therapeutic application

included patients prescribed dulaglutide, exenatide, liraglutide, or semaglutide, and assessed discontinuation rates for patients with diabetes only, diabetes and obesity, or obesity only, finding obesity only patients had the highest discontinuation rate (50.3% at 1 year) [27]

10.2337/dc13-2761 52 NaveedM.PerezC.AhmadE.RussellL.LeesZ.MayburyC

Experiencing mild side effects during the first few weeks of GLP-1 therapy is common

Tirzepatide is contraindicated in patients with a known prior serious hypersensitivity to the drug or its excipients

Patients on these medications are losing weight in record amounts over relatively short time periods